Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
11.80
+0.40 (3.51%)
At close: Jan 1, 2026
Indo-Bangla Pharmaceuticals Company Description
Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
The company’s principal products include Omeprazole, Esomeprazole, Dexamethasone, Domperidone, Metronidazole, Montelukast, Paracetamol, Sildenafil Citrate, and several other formulations.
It markets its products in various forms, such as tablets, capsules. Indo-Bangla Pharmaceuticals Limited was founded in 1954 and is based in Dhaka, Bangladesh.
Indo-Bangla Pharmaceuticals Limited
| Country | Bangladesh |
| Founded | 1954 |
| Industry | Pharmaceutical Preparations |
| Employees | 127 |
| CEO | A. F. M. Huq |
Contact Details
Address: Plot No. #183, Block #B Dhaka, 1229 Bangladesh | |
| Phone | 880 2 9678 777995 |
| Website | indo-banglapharma.com |
Stock Details
| Ticker Symbol | IBP |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| A. F. M. Huq | Chief Executive Officer |
| Syed Md. Shakib | Chief Financial Officer |